Cost-impact analysis of baroreflex activation therapy in chronic heart failure patients in the United States

BACKGROUND: The study evaluated the cost of baroreflex activation therapy plus guideline directed therapy (BAT + GDT) compared to GDT alone for HF patients with reduced ejection fraction and New York Heart Association Class III or II (with a recent history of III). Baroreflex activation therapy (BAT...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisognano, John, Schneider, John E., Davies, Shawn, Ohsfeldt, Robert L., Galle, Elizabeth, Stojanovic, Ivana, Deering, Thomas F., Lindenfeld, JoAnn, Zile, Michael R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995802/
https://www.ncbi.nlm.nih.gov/pubmed/33771104
http://dx.doi.org/10.1186/s12872-021-01958-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995802/
https://www.ncbi.nlm.nih.gov/pubmed/33771104
http://dx.doi.org/10.1186/s12872-021-01958-y

Ejemplares similares